Bed Bath & Beyond falters after Q1 earnings miss, plans to close 200 stores; PTC rallies on guided ARR, revenue growth Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
- EXFO (EXFO) up 31.1%
- Saratoga Investment (SAR) up 2.6%
ALSO HIGHER
- Acer Therapeutics (ACER) up 35.4% after positive data from food effect study of ACER-001
- OptiNose (OPTN) up 31.5% after entering co-promotion agreement for Xhance with kaleo
- AnaptysBio (ANAB) up 13.1% after getting orphan drug designation of imsidolimab for pustular psoriasis
- Veritone (VERI) up 12.7% after raising Q2 guidance
- PTC (PTC) up 5.7% after guiding Q3 revenue up double-digits
- SAP (SAP) up 5.5% after Q2 revenue guidance, affirmed FY20 outlook
- Crinetics Pharma (CRNX) up 3.7% after getting orphan drug designation for paltusotine to treat acromegaly
- Farfetch Ltd (FTCH) up 1.5% after being upgraded to Buy at China Renaissance
- Costco (COST) up 1.4% after reporting June sales
- Regeneron (REGN) up 0.7% after being upgraded to Buy at SunTrust
DOWN AFTER EARNINGS
- Bed Bath & Beyond (BBBY) down 5.6%
ALSO LOWER
- Otonomy (OTIC) down 7.3% after equity offering
- TD Holdings (GLG) down 4.5% after filing mixed securities shelf
- Turning Point Brands (TPB) down 4.0% after equity offering
- Five Below (FIVE) down 1.4% after disclosing $10M stock sale by chairman
Symbols:
EXFO SAR ACER OPTN ANAB VERI PTC SAP CRNX FTCH COST - $316.38 /
+0.095 (+0.03%)
REGN BBBY OTIC GLG TPB FIVE Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, Bed Bath Beyond, PTC